A Study of a Single Dose of ALXN1210 in Healthy Participants

NCT05288660 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ALXN1210
DRUG: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.